Skip to content

Self-administered COgnitive Personalized Training in Early Psychosis

Self-administered COgnitive Personalized Training in Early Psychosis: a Randomized Controlled Trial in Adolescents and Young Adults to Assess Efficacy and Efficiency of an EHealth Application Providing Personalized Cognitive Training

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06634446
Acronym
SCOPe
Enrollment
240
Registered
2024-10-10
Start date
2021-10-26
Completion date
2027-12-30
Last updated
2024-10-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

First Episode Psychosis (FEP)

Keywords

First Episode Psychosis (FEP),, schizophrenia, Cognitive Personalized training, adolescents and young adults FEP, personalized cognitive training, Chronic psychosis, Biological Testing, Metabolic Alterations

Brief summary

The overall objective of SCOPe is to improve early intervention in psychosis by providing an innovative eHealth tool that will enable personalized cognitive training, adapted to the individual's cognitive abilities. Cognitive remediation improves quality of life and functional outcome in patients with chronic psychosis. It would even be more efficacious in the early phase of psychosis by tackling the negative impact of psychosis on education achievement and employment. However, cognitive dysfunctions are often overlooked in FEP and cognitive remediation is not always accessible. New technologies can provide us with youth-friendly, non-stigmatizing tools, such as self administered, training applications so that all first-line clinical settings or professionals, and in fine all patients, can have access, wherever they live, to personalized cognitive training focusing on impaired functions. Early psychosis can be associated with inflammation, metabolic deficiency, as well as early structural brain anomalies that reflect brain plasticity abilities and could influence the prognosis and response to cognitive training. Our background hypothesis is that promoting neuroplasticity by cognitive training could attenuate or reverse early cognitive deficits and improve the overall functional outcome in young patients experiencing FEP and that this effect is modulated by individual brain plasticity abilities.

Interventions

DEVICEa mobile application for cognitive training

Personalized cognitive training (PCT) HappyNeuronwill be delivered via a tablet or mobile application for 24 hours within 12 weeks, with a weekly supervision-call to reinforce their motivation. HappyNeuron Pro is a digital therapy tool designed for clinicians to provide engaging cognitive therapy via a web-based platform. It is compatible with PC, Mac, iPad, and Android devices and is available in multiple languages. The tool features exercises from established cognitive remediation programs. Functionality: The program offers 22 cognitive exercises targeting seven key functions outlined in the MATRICS framework: Processing Speed, Selective Attention, Reasoning and Working Memory, Verbal Memory, Visual Memory, and Auditory Memory. Exercises are customizable to meet individual patient needs, facilitating personalized cognitive training. User Experience: Each session comprises brief, self-administered exercises, with the order and difficulty adjusted by clinicians.

Patients in the control group will use video games with no prominent cognitive involvement no prominent cognitive involvement

Sponsors

Centre Hospitalier St Anne
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
16 Years to 35 Years
Healthy volunteers
Yes

Inclusion criteria

* Adolescent and young adults, both genders, aged 16 to 35, * Seeking help in one of the recruiting centers, * Newly diagnosed as experiencing an Episode of Psychosis (reaching criteria as described in the Comprehensive Assessment of at Risk Mental States (CAARMS) within the year * Written informed consent signed (and from one legal guardian for minors).

Exclusion criteria

* Severe and unstabilized medical conditions, * Insufficient level in reading and/or French language, * Absence of medical insurance, * Participation in another intervention trial, * Enforced hospitalization (ASPDT, ASPPI, ASPRE), * Intellectuel Deficiency (IQ<70), and / or sensorimotor deficits incompatible with the cognitive training,

Design outcomes

Primary

MeasureTime frameDescription
Primary assessment criterionMonth 9The main outcome will be the global functioning measured by the Personal and Social Performance (PSP) Scale after 3 months of cognitive training . The PSP is a 100-point single-item rating scale. The ratings are done by a clinician, in 5-10 min, and require minimal training, with excellent inter-rater reliability. The scale considers four main areas: 1. socially useful activities; 2. personal and social relationships; 3. self-care; and 4) disturbing and aggressive behaviours during a determined reference period (hereit will be the last month). It was found to be a quick and valid measure, sensitive to change, of patients; personal and social functioning even in early stage of psychosis.

Countries

France

Contacts

Primary ContactMarie Odile KREBS, PROFESSEUR
MO.KREBS@ghu-paris.fr+331 456 586 46
Backup ContactLinda SCORIELS, PhD
scoriels@ghu-paris.fr+33140789269

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026